StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Artelo Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$11.07M. For fiscal 2025 it was -$11.40M. The highest annual figure on record is -$15.24K in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.40M–
FY2024Dec 31, 2024-$10.11M–
FY2023Dec 31, 2023-$9.93M–
FY2021Aug 31, 2021-$7.44M–
FY2020Aug 31, 2020-$4.69M–
FY2019Aug 31, 2019-$3.21M–
FY2018Aug 31, 2018-$2.34M–
FY2017Aug 31, 2017-$232.79K–
FY2016Aug 31, 2016-$29.69K–
FY2015Aug 31, 2015-$15.24K–
FY2014Aug 31, 2014-$15.27K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$2.51M–
Q1 FY2026CQ1 2026Mar 31, 2026-$2.69M–
Q4 FY2025CQ4 2025Dec 31, 2025-$2.79M–
Q3 FY2025CQ3 2025Sep 30, 2025-$3.09M–
Q2 FY2025CQ2 2025Jun 30, 2025-$3.15M–
Q1 FY2025CQ1 2025Mar 31, 2025-$2.38M–
Q4 FY2024CQ4 2024Dec 31, 2024-$3.81M–
Q3 FY2024CQ3 2024Sep 30, 2024-$1.20M–
Q2 FY2024CQ2 2024Jun 30, 2024-$2.51M–
Q1 FY2024CQ1 2024Mar 31, 2024-$2.59M–
Q4 FY2023CQ4 2023Dec 31, 2023-$3.24M–
Q3 FY2023CQ3 2023Sep 30, 2023-$2.61M–
Q2 FY2023CQ2 2023Jun 30, 2023-$1.78M–
Q1 FY2023CQ1 2023Mar 31, 2023-$2.29M–
Q4 FY2021CQ3 2021Aug 31, 2021-$1.89M–
Q3 FY2021CQ2 2021May 31, 2021-$2.25M–
Q2 FY2021CQ1 2021Feb 28, 2021-$1.87M–
Q1 FY2021CQ4 2020Nov 30, 2020-$1.44M–
Q4 FY2020CQ3 2020Aug 31, 2020-$1.03M–
Q3 FY2020CQ2 2020May 31, 2020-$951.40K–
Q2 FY2020CQ1 2020Feb 29, 2020-$1.37M–
Q1 FY2020CQ4 2019Nov 30, 2019-$1.34M–
Q4 FY2019CQ3 2019Aug 31, 2019-$953.42K–
Q3 FY2019CQ2 2019May 31, 2019-$941.29K–
Q2 FY2019CQ1 2019Feb 28, 2019-$757.92K–
Q1 FY2019CQ4 2018Nov 30, 2018-$556.90K–
Q4 FY2018CQ3 2018Aug 31, 2018-$690.11K–
Q3 FY2018CQ2 2018May 31, 2018-$577.86K–
Q2 FY2018CQ1 2018Feb 28, 2018-$798.46K–
Q1 FY2018CQ4 2017Nov 30, 2017-$277.06K–
Q4 FY2017CQ3 2017Aug 31, 2017-$115.55K–
Q3 FY2017CQ2 2017May 31, 2017-$95.73K–
Q2 FY2017CQ1 2017Feb 28, 2017-$12.00K–
Q1 FY2017CQ4 2016Nov 30, 2016-$9.52K–
Q4 FY2016CQ3 2016Aug 31, 2016-$4.33K–
Q3 FY2016CQ2 2016May 31, 2016-$5.05K–
Q2 FY2016CQ1 2016Feb 29, 2016-$5.09K–
Q1 FY2016CQ4 2015Nov 30, 2015-$15.22K–
Q4 FY2015CQ3 2015Aug 31, 2015-$4.59K–
Q3 FY2015CQ2 2015May 31, 2015-$2.50K–

More Artelo Biosciences figures

See a number that looks wrong?